NASDAQ

Context Therapeutics Inc. (CNTX)

♥ 383 Thanks from members

Live price chart, market sentiment, and community perspectives for Context Therapeutics Inc. (NASDAQ: CNTX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Context Therapeutics FoundersLeadership: Martin Lehr (CEO)Leadership: Executive Science TeamHolder: Specialized Biotech FundsHolder: Venrock Healthcare PartnersCLDN6 Targeted TherapiesProgesterone Receptor AntagonistsOncology Pipeline Compounds#CNTX#Context Therapeutics#NASDAQ CNTX#womens oncology biotech#clinical-stage pharma